HIGHLIGHTS
- who: Po-Hsun Huang from the Medical University of Vienna, Austria have published the research work: Association of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Use With Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Patients With Stabilized Acute Myocardial Infarction: A Propensity Score Matching Study, in the Journal: (JOURNAL)
- what: This study was designed to investigate the effect of SGLT2 inhibitors on long-term cardiovascular and renal outcomes in T2DM patients after successful revascularization and stabilization of AMI.
- how: Based on the data of these CVOTs a metaanalysis concluded that SGLT2 inhibitors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.